Menu Search
Equities

Visiomed Group SA

7V91:STU

Visiomed Group SA

Actions
  • Price (EUR)0.1792
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change-56.94%
  • Beta--
Data delayed at least 15 minutes, as of May 16 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Visiomed Group SA is a France-based company. The Company is primarily engaged in the design, manufacture and marketing of medical electronics. It develops and markets health products in the fields of medical and well-being self-diagnosis to provide non-drug prevention and treatment solutions. The Company's product portfolio comprises MyThermo, an infrared contact-less medical thermometer; MyTension, an automatic blood pressure and pulse monitors; MyOxy, a finger pulse oximeter; MyECG, a pocket electrodiogram; MyGluco, a blood sugar meter; My Coach, a health and fitness coach, and Epiderm, a telemedicine dermatology mobile application, among others. The Company serves pharmacies, health professionals, hospitals, clinics and retirement homes. It also offers connected solutions and COVID devices such as deconfinement kits, masks, filter cushion, serological tests etc. The Company’s subsidiaries include ThermoFlash and BewellConnect.

  • Revenue in EUR (TTM)13.71m
  • Net income in EUR902.00k
  • Incorporated2009
  • Employees94.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.